{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:13:30Z","timestamp":1771341210387,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00849-6","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:04:12Z","timestamp":1769321052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of differentiated antiretroviral therapy delivery models for stable persons living with HIV in Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Abebe Dires","family":"Nega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulusew Andualem","family":"Asemahagn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fentie Ambaw","family":"Getahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"849_CR1","unstructured":"WHO. HIV\/AIDS: Key facts. 2024."},{"key":"849_CR2","unstructured":"WHO. Global HIV Programme: HIV data and statistics: Africa region. 2024."},{"key":"849_CR3","unstructured":"WHO. World health statistics: monitoring health for the SDGs. Sustainable Development Goals; 2023."},{"issue":"6","key":"849_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/hiv.12841","volume":"21","author":"M Davari","year":"2020","unstructured":"Davari M, Giwa H, Nabizade A, Taheri F, Giwa A. Antiretroviral therapy and the risk of sexual transmission of HIV: a systematic review and meta?analysis. HIV Med. 2020;21(6):349\u201357.","journal-title":"HIV Med"},{"key":"849_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11904-019-00454-5","volume":"16","author":"M Roy","year":"2019","unstructured":"Roy M, Bolton Moore C, Sikazwe I, Holmes CB. A review of differentiated service delivery for HIV treatment: effectiveness, mechanisms, targeting, and scale. Curr HIV\/AIDS Rep. 2019;16:324\u201334.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"13","key":"849_CR6","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/QAD.0000000000003033","volume":"35","author":"CW Claassen","year":"2021","unstructured":"Claassen CW, Lindsay B, Riedel DJ, Kafunda I, Mwango L, Hachaambwa L, et al. Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs. Aids. 2021;35(13):2234\u20135.","journal-title":"Aids"},{"issue":"5","key":"849_CR7","doi-asserted-by":"publisher","first-page":"e26275","DOI":"10.1002\/jia2.26275","volume":"27","author":"DA Moiana Uetela","year":"2024","unstructured":"Moiana Uetela DA, Zimmermann M, Chicumbe S, Gudo ES, Barnabas R, Uetela OA, et al. Cost-Effectiveness and budget impact analysis of the implementation of differentiated service delivery models for HIV treatment in mozambique: a modelling study. J Int AIDS Soc. 2024;27(5):e26275.","journal-title":"J Int AIDS Soc"},{"key":"849_CR8","first-page":"82","volume":"82","author":"DA Roberts","year":"1999","unstructured":"Roberts DA, Tan N, Limaye N, Irungu E, Barnabas RV. Cost of differentiated HIV antiretroviral therapy delivery strategies in sub-Saharan africa: a systematic review. J Acquir Immune Defic Syndr. 1999;82:82.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"849_CR9","doi-asserted-by":"crossref","unstructured":"Rosen S, Nichols B, Guthrie T, Benade M, Kuchukhidze S, Long L. Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017\u20132019. Gates Open Res. 2021;5.","DOI":"10.12688\/gatesopenres.13458.1"},{"issue":"11","key":"849_CR10","doi-asserted-by":"publisher","first-page":"e25640","DOI":"10.1002\/jia2.25640","volume":"23","author":"L Long","year":"2020","unstructured":"Long L, Kuchukhidze S, Pascoe S, Nichols BE, Fox MP, Cele R, et al. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub?Saharan africa: a rapid systematic review. J Int AIDS Soc. 2020;23(11):e25640.","journal-title":"J Int AIDS Soc"},{"key":"849_CR11","unstructured":"WHO. Updated recommendations on service delivery for the treatment and care of people living with HIV. 2021."},{"key":"849_CR12","doi-asserted-by":"crossref","unstructured":"Hanrahan CF, Schwartz SR, Mudavanhu M, West NS, Mutunga L, Keyser V et al. The impact of community-versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: findings from a pragmatic randomized controlled trial in South Africa. PLoS Med. 2019;16(5).","DOI":"10.1371\/journal.pmed.1002808"},{"issue":"15","key":"849_CR13","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1097\/QAD.0000000000003385","volume":"36","author":"L Myer","year":"2022","unstructured":"Myer L, Odayar J, Malaba TR, Allerton J, Kabanda S, Hu NC, et al. Improved virologic outcomes in postpartum women living with HIV referred to differentiated models of care. AIDS. 2022;36(15):2203\u201311.","journal-title":"AIDS"},{"issue":"9","key":"849_CR14","doi-asserted-by":"publisher","first-page":"e1002659","DOI":"10.1371\/journal.pmed.1002659","volume":"15","author":"P Geldsetzer","year":"2018","unstructured":"Geldsetzer P, Francis JM, Sando D, Asmus G, Lema IA, Mboggo E, et al. Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar Es Salaam, Tanzania. PLoS Med. 2018;15(9):e1002659.","journal-title":"PLoS Med"},{"key":"849_CR15","doi-asserted-by":"crossref","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ, Sterne JAC. Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) SHORT VERSION (CRIBSHEET). Br Med J [Internet]. 2019;(July):1\u201324. Available from: https:\/\/methods.cochrane.org\/","DOI":"10.1002\/9781119536604.ch8"},{"key":"849_CR16","doi-asserted-by":"publisher","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods [Internet]. n\/a(n\/a). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/jrsm.1411","DOI":"10.1002\/jrsm.1411"},{"key":"849_CR17","unstructured":"Cochrane. Cochreane Handbook and manuals: Assessing the certainty or quality of a body of evidence. 2025."},{"key":"849_CR18","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Higgins JPT, Altman DG, Group CSM. Analysing data and undertaking meta-analyses. Cochrane Handb Syst Rev Interv. 2019;241\u201384.","DOI":"10.1002\/9781119536604.ch10"},{"issue":"2","key":"849_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193.","journal-title":"Psychol Methods"},{"issue":"3","key":"849_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785\u201394.","journal-title":"Biometrics"},{"issue":"23","key":"849_CR21","doi-asserted-by":"publisher","first-page":"e15987","DOI":"10.1097\/MD.0000000000015987","volume":"98","author":"L Shi","year":"2019","unstructured":"Shi L, Lin L. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Med (Baltim). 2019;98(23):e15987.","journal-title":"Med (Baltim)"},{"key":"849_CR22","unstructured":"Goodrich S, Siika A, Mwangi A, Nyambura M, Naanyu V, Yiannoutsos C et al. IMPLEMENTATION SCIENCE Development, Assessment, and Outcomes of a Community-Based Model of Antiretroviral Care in Western Kenya Through a Cluster-Randomized Control Trial [Internet]. Available from: www.jaids.com"},{"key":"849_CR23","doi-asserted-by":"crossref","unstructured":"Fox MP, Pascoe S, Huber AN, Murphy J, Phokojoe M, Gorgens M et al. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. PLoS Med. 2019;16(7).","DOI":"10.1371\/journal.pmed.1002874"},{"key":"849_CR24","doi-asserted-by":"publisher","unstructured":"Cassidy T, Grimsrud A, Keene C, Lebelo K, Hayes H, Orrell C et al. Twenty-four-month outcomes from a cluster-randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs. 2020; Available from: http:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/jia2.25649\/full","DOI":"10.1002\/jia2.25649\/full"},{"key":"849_CR25","unstructured":"Tukei BBB, Fatti G, \u2026 ATJJ of, 2020 undefined, Tiam A, Ngorima-Mabhena N, et al.Twelve-month outcomes of community-based differentiated models of multimonth dispensing of ART among stable HIV-infected adults in Lesotho: a cluster. journals.lww.com [Internet].2020 [cited 2024 Oct 13]; Available from: https:\/\/journals.lww.com\/jaids\/fulltext\/2020\/11010\/twelve_month_outcomes_of_community_based.6.aspx."},{"issue":"11","key":"849_CR26","doi-asserted-by":"publisher","first-page":"e0277018","DOI":"10.1371\/journal.pone.0277018","volume":"17","author":"J Odayar","year":"2022","unstructured":"Odayar J, Malaba TR, Allerton J, Kabanda S, Huang D, Kalombo C, et al. Virologic outcomes after early referral of stable HIV-positive adults initiating ART to community-based adherence clubs in cape Town, South africa: A randomised controlled trial. PLoS ONE. 2022;17(11):e0277018.","journal-title":"PLoS ONE"},{"key":"849_CR27","doi-asserted-by":"crossref","unstructured":"Fatti G, Ngorima-Mabhena N, Mothibi E, Muzenda T, Choto R, Kasu T et al. Outcomes of Three-Versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe [Internet]. Vol. 84, Journal of acquired immune deficiency syndromes (1999). United States; 2020 Jun. Available from: www.jaids.com.","DOI":"10.1097\/QAI.0000000000002333"},{"issue":"2","key":"849_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/QAI.0000000000003176","volume":"93","author":"M Wang","year":"2023","unstructured":"Wang M, Violette LR, Dorward J, Ngobese H, Sookrajh Y, Bulo E, et al. Delivery of Community-based antiretroviral therapy to maintain viral suppression and retention in care in South Africa. J Acquir Immune Defic Syndr. 2023;93(2):126\u201333.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"849_CR29","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2352-3018(21)00242-3","volume":"9","author":"M Limbada","year":"2022","unstructured":"Limbada M, Macleod D, Situmbeko V, Muhau E, Shibwela O, Chiti B, et al. Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial. Lancet HIV. 2022;9(1):e13\u201323.","journal-title":"Lancet HIV"},{"issue":"1","key":"849_CR30","doi-asserted-by":"publisher","first-page":"e1004150","DOI":"10.1371\/journal.pmed.1004150","volume":"20","author":"M Kopo","year":"2023","unstructured":"Kopo M, Lejone TI, Tschumi N, Glass TR, Kao M, Brown JA, et al. Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in lesotho: the PEBRA cluster-randomized trial. PLoS Med. 2023;20(1):e1004150.","journal-title":"PLoS Med"},{"issue":"8","key":"849_CR31","doi-asserted-by":"publisher","first-page":"e0000108","DOI":"10.1371\/journal.pgph.0000108","volume":"2","author":"C Bolton Moore","year":"2022","unstructured":"Bolton Moore C, Pry JM, Mukumbwa-Mwenechanya M, Eshun-Wilson I, Topp S, Mwamba C, et al. A controlled study to assess the effects of a fast track (FT) service delivery model among stable HIV patients in Lusaka Zambia. PLOS Glob Public Heal. 2022;2(8):e0000108.","journal-title":"PLOS Glob Public Heal"},{"issue":"5","key":"849_CR32","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1016\/S2214-109X(21)00039-5","volume":"9","author":"RM Hoffman","year":"2021","unstructured":"Hoffman RM, Moyo C, Balakasi KT, Siwale Z, Hubbard J, Bardon A, et al. Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial. Lancet Glob Heal. 2021;9(5):e628\u201338.","journal-title":"Lancet Glob Heal"},{"key":"849_CR33","doi-asserted-by":"publisher","unstructured":"Roy M, Bolton-Moore C, Sikazwe I, Mukumbwa-Mwenechanya M, Efronson E, Mwamba C et al. Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial. PLoS Med [Internet]. 2020;17(7):1\u201319. Available from: https:\/\/doi.org\/10.1371\/journal.pmed.1003116","DOI":"10.1371\/journal.pmed.1003116"},{"key":"849_CR34","unstructured":"WHO. consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. 2021."},{"key":"849_CR35","unstructured":"IAS. Summery of published evidences [Internet]. 2020. Available from: https:\/\/www.iasociety.org\/"},{"key":"849_CR36","doi-asserted-by":"crossref","unstructured":"Limbada M, Zijlstra G, Macleod D, Ayles H, Fidler S. A systematic review of the effectiveness of non- health facility based care delivery of antiretroviral therapy for people living with HIV in sub-Saharan Africa measured by viral suppression, mortality and retention on ART. BMC Public Health. 2021;21(1).","DOI":"10.1186\/s12889-021-11053-8"},{"key":"849_CR37","doi-asserted-by":"crossref","unstructured":"Pellecchia U, Baert S, Nundwe S, Bwanali A, Zamadenga B, Metcalf CA et al. We are part of a family. Benefits and limitations of community ART groups (CAGs) in Thyolo, malawi: A qualitative study. J Int AIDS Soc. 2017;20(1).","DOI":"10.7448\/IAS.20.1.21374"},{"issue":"5","key":"849_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"RW Eisinger","year":"2019","unstructured":"Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451\u20132.","journal-title":"JAMA"},{"key":"849_CR39","unstructured":"WHO. HIV\/AIDS: Africa, Disease burden. 2024."},{"key":"849_CR40","unstructured":"IAS. differentlated service delivery for HIV treatment: summary of published evidence. 2020."},{"issue":"6","key":"849_CR41","doi-asserted-by":"publisher","first-page":"e25704","DOI":"10.1002\/jia2.25704","volume":"24","author":"A Grimsrud","year":"2021","unstructured":"Grimsrud A, Wilkinson L. Acceleration of differentiated service delivery for HIV treatment in sub?Saharan Africa during COVID?19. J Int AIDS Soc. 2021;24(6):e25704.","journal-title":"J Int AIDS Soc"},{"key":"849_CR42","doi-asserted-by":"crossref","unstructured":"Bailey LE, Siberry GK. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis. 24 Suppl. 2021;6(Suppl 6).","DOI":"10.1002\/jia2.25794"},{"key":"849_CR43","doi-asserted-by":"crossref","unstructured":"Jamieson L, Rosen S, Phiri B, Grimsrud A, Mwansa M, Shakwelele H et al. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia. BMJ Open [Internet]. 2022 Dec 1 [cited 2024 Oct 8];12(12):e064070. Available from: https:\/\/bmjopen.bmj.com\/content\/12\/12\/e064070","DOI":"10.1136\/bmjopen-2022-064070"},{"key":"849_CR44","doi-asserted-by":"publisher","unstructured":"Lewis L, Sookrajh Y, Gate K, Khubone T, Maraj M, Mkhize S et al. Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa. J Int AIDS Soc [Internet]. 2021 Oct 1 [cited 2024 Oct 8];24(S6):e25802. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1002\/jia2.25802","DOI":"10.1002\/jia2.25802"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00849-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:26:42Z","timestamp":1771338402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00849-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["849"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00849-6","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}